News articles for Vanda Pharmaceuticals Inc.:
Thursday, April 18, 2013
Wednesday, April 17, 2013
Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
WASHINGTON, April 17, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), announced today that it has named Paolo Baroldi, M.D., Ph.D. as its Senior Vice President and Chief Medical Officer.
Dr. Baroldi has over 30 years of clinical development experience in many therapeutic areas, including neurology and ... read more
Thursday, April 4, 2013
Monday, March 25, 2013
Thursday, March 14, 2013
Wednesday, February 27, 2013
Tuesday, February 12, 2013
Vanda Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 Results
WASHINGTON, Feb. 12, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced financial and operational results for the fourth quarter and full year ended December 31, 2012.
... read more
Thursday, January 31, 2013